|
Reference | Year | Age | Lesion characteristics | Surgical treatment | Pathology | Multimodality therapy | Outcome |
|
Our case | 2014 | 69 | Ventrolateral medulla | Biopsy via far lateral approach | GBM | Temozolomide and radiation | Died 11 months after diagnosis |
|
Hundsberger et al. [2] | 2014 | 48 | Pons/medulla | Biopsy | US | US | US |
55 | Medulla | Biopsy | US | US | US |
|
Babu et al. [4] | 2013 | >60 | Pons, MCP, medulla | US | US | US | US |
|
Yoshikawa et al. [5] | 2013 | 63 | Ventral, diffuse medulla | None (diagnosis made at autopsy) | GBM | Temozolomide and radiation (tolerated for only 4 days) | Died 18 days after treatment |
|
Chotai et al. [6] | 2012 | 51 | Dorsal, exophytic medulla | NTR via suboccipital approach | GBM | Temozolomide and radiation | 19 months postsurgical survival |
|
Lakhan and Harle [7] | 2009 | 48 | Diffuse, pons, medulla, cervical spine | None (diagnosis made at autopsy) | GBM | None | Died 4 weeks after presentation |
|
Luetjens et al. [8] | 2009 | 40 | Dorsal, exophytic medulla | NTR via suboccipital approach | GBM | Temozolomide and radiation | Two years postsurgical survival |
|
Shad et al. [9] | 2005 | 28 | Pons, medulla | Sx biopsy | AA | US | US |
|
Kyoshima et al. [10] | 2004 | 55 | Dorsal, exophytic, medulla | GTR via suboccipital approach | GBM | Radiation for recurrence 1 year and 8 months postoperatively | Died 2 years and 3 months after surgery |
|
Massager et al. [11] | 2000 | 34 | Medulla | US | AA | US | US |
37 | Medulla | US | AA | US | US |
|
Sahni et al. [12] | 1987 | 24 | Medulla | Sx biopsy | AA | Radiation | US |
27 | Cervicomedullary junction | Sx biopsy | AA | Radiation | Died 1.5 years after surgery |
30 | Medulla, 4th ventricle | Sx biopsy | AA | Radiation | US |
|